Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin’s lymphomas. Functional ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1997-01

AUTHORS

D M Jadayel, J Lukas, E Nacheva, J Bartkova, G Stranks, P J De Schouwer, D Lens, J Bartek, M J Dyer, A R Kruger, D Catovsky

ABSTRACT

Abnormalities of several cell-cycle regulatory genes including cyclin D1, p16CDKN2 and p15CDKN2B have been described in B cell non-Hodgkin's lymphoma (B-NHL). We describe a new B-NHL cell line (Granta 519), with concurrent abnormalities of the cyclin D1, pl6CDKN2 and pl5CDKN2B genes. An independent clinical case of mantle cell NHL (Mc-NHL) with concomitant overexpression of cyclin D1, and deletion of the p16CDKN2 gene was also identified, suggesting that this combination of oncogenic aberration is a pathophysiologic contribution to a subset of NHL cases. More in-depth functional studies of this concept were facilitated by the availability of the cell line Granta 519 which was derived from a case of high-grade NHL and has a mature B cell immunophenotype. Cytogenetic analysis identified translocation t(11;14)(q13;q32) and complex rearrangements involving chromosomes 9p22, 13p21, 17pl1, and 18q21. Molecular analysis identified overexpression of cyclin D1 mRNA and biallelic deletion of the p16CDKN2 and p15CDKN2B genes. To elucidate the effect of these genetic abnormalities on the G1 control of Granta 519 cells, the level and function of the major components of the cyclinD/retinoblastoma (RB) pathway were investigated. Cyclin D1 was dominant among the D-type cyclins, formed abundant complexes with cyclin-dependent kinase (Cdk) Cdk4 rather than Cdk6, and the immunoprecipitated cyclin D1/Cdk4 holoenzyme was active as a pRB kinase. Electroporation of wild-type pl6CDKN2 arrested the Granta 519 cells in G1, consistent with the p16CDKN2 loss as a biologically relevant event during multistep evolution of the tumor, and with the expression of functional pRB. Direct cooperation of these distinct abnormalities to cell-cycle, deregulation in NHL cells was suggested by G1 acceleration upon inducible overexpression of cyclin D1 in a control breast cancer cell line lacking p16CDKN2, an effect which could be prevented by ectopic expression of p16CDKN2. Taken together, these data suggest that concurrent overexpression of cyclin D1 and functional elimination of p16CDKN2 and p15CDKN2B may characterize certain cases of mantle cell NHL, and that cooperation of the abnormalities is likely to provide a growth advantage of the tumour cells through more efficient inactivation of the RB tumor suppressor. Further clinicopathologic studies of this possibility are warranted. More... »

PAGES

2400555

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.leu.2400555

DOI

http://dx.doi.org/10.1038/sj.leu.2400555

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1039379852

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9001420


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carrier Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Cycle Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosomes, Human, Pair 11", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosomes, Human, Pair 14", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclin D1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclin-Dependent Kinase Inhibitor p15", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclin-Dependent Kinase Inhibitor p16", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Deletion", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genes, Tumor Suppressor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunophenotyping", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Karyotyping", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma, B-Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oncogene Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Messenger", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Translocation, Genetic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Suppressor Proteins", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Academic Department of Haematology and Cytogenetics, Institute of Cancer Research, Royal Marsden Hospital Sutton, Surrey, UK."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jadayel", 
        "givenName": "D M", 
        "id": "sg:person.01013047576.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013047576.49"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Lukas", 
        "givenName": "J", 
        "id": "sg:person.01235271253.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235271253.45"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Nacheva", 
        "givenName": "E", 
        "id": "sg:person.014452760564.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014452760564.20"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Bartkova", 
        "givenName": "J", 
        "id": "sg:person.0742723433.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742723433.90"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Stranks", 
        "givenName": "G", 
        "id": "sg:person.01270720062.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270720062.78"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "De Schouwer", 
        "givenName": "P J", 
        "id": "sg:person.01134032473.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134032473.64"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Lens", 
        "givenName": "D", 
        "id": "sg:person.01021077160.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021077160.42"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Bartek", 
        "givenName": "J", 
        "id": "sg:person.016567135244.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016567135244.53"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Dyer", 
        "givenName": "M J", 
        "id": "sg:person.016661524712.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016661524712.35"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Kruger", 
        "givenName": "A R", 
        "id": "sg:person.01303002216.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303002216.30"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Catovsky", 
        "givenName": "D", 
        "id": "sg:person.01225221362.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225221362.51"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0092-8674(94)90540-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001605098"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/gcc.2870050210", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004299310"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/370183a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009320671", 
          "https://doi.org/10.1038/370183a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/mcb.14.3.2077", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013411441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/mcb.14.3.2066", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014240465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0795-686", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016345098", 
          "https://doi.org/10.1038/nm0795-686"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/375503a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034728495", 
          "https://doi.org/10.1038/375503a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/mcb.15.5.2600", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035576061"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0092-8674(95)90385-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044189874"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.7809631", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062649804"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1997-01", 
    "datePublishedReg": "1997-01-01", 
    "description": "Abnormalities of several cell-cycle regulatory genes including cyclin D1, p16CDKN2 and p15CDKN2B have been described in B cell non-Hodgkin's lymphoma (B-NHL). We describe a new B-NHL cell line (Granta 519), with concurrent abnormalities of the cyclin D1, pl6CDKN2 and pl5CDKN2B genes. An independent clinical case of mantle cell NHL (Mc-NHL) with concomitant overexpression of cyclin D1, and deletion of the p16CDKN2 gene was also identified, suggesting that this combination of oncogenic aberration is a pathophysiologic contribution to a subset of NHL cases. More in-depth functional studies of this concept were facilitated by the availability of the cell line Granta 519 which was derived from a case of high-grade NHL and has a mature B cell immunophenotype. Cytogenetic analysis identified translocation t(11;14)(q13;q32) and complex rearrangements involving chromosomes 9p22, 13p21, 17pl1, and 18q21. Molecular analysis identified overexpression of cyclin D1 mRNA and biallelic deletion of the p16CDKN2 and p15CDKN2B genes. To elucidate the effect of these genetic abnormalities on the G1 control of Granta 519 cells, the level and function of the major components of the cyclinD/retinoblastoma (RB) pathway were investigated. Cyclin D1 was dominant among the D-type cyclins, formed abundant complexes with cyclin-dependent kinase (Cdk) Cdk4 rather than Cdk6, and the immunoprecipitated cyclin D1/Cdk4 holoenzyme was active as a pRB kinase. Electroporation of wild-type pl6CDKN2 arrested the Granta 519 cells in G1, consistent with the p16CDKN2 loss as a biologically relevant event during multistep evolution of the tumor, and with the expression of functional pRB. Direct cooperation of these distinct abnormalities to cell-cycle, deregulation in NHL cells was suggested by G1 acceleration upon inducible overexpression of cyclin D1 in a control breast cancer cell line lacking p16CDKN2, an effect which could be prevented by ectopic expression of p16CDKN2. Taken together, these data suggest that concurrent overexpression of cyclin D1 and functional elimination of p16CDKN2 and p15CDKN2B may characterize certain cases of mantle cell NHL, and that cooperation of the abnormalities is likely to provide a growth advantage of the tumour cells through more efficient inactivation of the RB tumor suppressor. Further clinicopathologic studies of this possibility are warranted.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.leu.2400555", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1097065", 
        "issn": [
          "0887-6924", 
          "1476-5551"
        ], 
        "name": "Leukemia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "name": "Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin\u2019s lymphomas. Functional studies in a cell line (Granta 519)", 
    "pagination": "2400555", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "bb960dcc56879c20698181892a3b6e9c60cf1d8c2ee66e759e7e675905f276e1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9001420"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8704895"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.leu.2400555"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1039379852"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.leu.2400555", 
      "https://app.dimensions.ai/details/publication/pub.1039379852"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29207_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.nature.com/articles/2400555"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2400555'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2400555'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2400555'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2400555'


 

This table displays all metadata directly associated to this object as RDF triples.

250 TRIPLES      21 PREDICATES      61 URIs      43 LITERALS      31 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.leu.2400555 schema:about N01f63cb866054265b45cba9ef6a0a9d5
2 N1fe16166d84b484c8d99c585d7dd9538
3 N20531dbecab9468c82022ac6f355e697
4 N2151b8c03a7e418d9b6731eaf63972c4
5 N29556449e9c14f51abb357cef33600b5
6 N40b3c8117947485191a1ecb655aba7b3
7 N4a576fee10c5430cb9d2515758886150
8 N6a106a6408634b14ae96e1f777b99ddc
9 N701a29fe40c7448e9c0d6a7c0b8047e0
10 N7b5a7b5f929d42c792eb303c46bdc43a
11 N809e84cefb994517b8a0da7b1fa46054
12 N9cbcfca7f44c46a6a1a36ffe18719844
13 Nab1c0ae177bc4dc5959d3b28ee4c05b9
14 Nad944655514f4c2ba3943781f58a8e5b
15 Nae6f06e8e38d42b1b9240eb681342938
16 Nb5e20822d3734ba2b8e56a1da62ed810
17 Nb5ebba50be844f7bb1836588d1cc3614
18 Nc4e63db731b741ba9e6e26cdd869a181
19 Nc8bacf2a19fa4002944b803e2512fc7c
20 Ne54245ee36684707b71abaa1ca747db4
21 Neb8111e684784106a278f80fdc71dd2f
22 Neec20345a37446338eee8e36088c3014
23 anzsrc-for:11
24 anzsrc-for:1112
25 schema:author Nefd32212e05e49dfad81b8c75cf1f932
26 schema:citation sg:pub.10.1038/370183a0
27 sg:pub.10.1038/375503a0
28 sg:pub.10.1038/nm0795-686
29 https://doi.org/10.1002/gcc.2870050210
30 https://doi.org/10.1016/0092-8674(94)90540-1
31 https://doi.org/10.1016/0092-8674(95)90385-2
32 https://doi.org/10.1126/science.7809631
33 https://doi.org/10.1128/mcb.14.3.2066
34 https://doi.org/10.1128/mcb.14.3.2077
35 https://doi.org/10.1128/mcb.15.5.2600
36 schema:datePublished 1997-01
37 schema:datePublishedReg 1997-01-01
38 schema:description Abnormalities of several cell-cycle regulatory genes including cyclin D1, p16CDKN2 and p15CDKN2B have been described in B cell non-Hodgkin's lymphoma (B-NHL). We describe a new B-NHL cell line (Granta 519), with concurrent abnormalities of the cyclin D1, pl6CDKN2 and pl5CDKN2B genes. An independent clinical case of mantle cell NHL (Mc-NHL) with concomitant overexpression of cyclin D1, and deletion of the p16CDKN2 gene was also identified, suggesting that this combination of oncogenic aberration is a pathophysiologic contribution to a subset of NHL cases. More in-depth functional studies of this concept were facilitated by the availability of the cell line Granta 519 which was derived from a case of high-grade NHL and has a mature B cell immunophenotype. Cytogenetic analysis identified translocation t(11;14)(q13;q32) and complex rearrangements involving chromosomes 9p22, 13p21, 17pl1, and 18q21. Molecular analysis identified overexpression of cyclin D1 mRNA and biallelic deletion of the p16CDKN2 and p15CDKN2B genes. To elucidate the effect of these genetic abnormalities on the G1 control of Granta 519 cells, the level and function of the major components of the cyclinD/retinoblastoma (RB) pathway were investigated. Cyclin D1 was dominant among the D-type cyclins, formed abundant complexes with cyclin-dependent kinase (Cdk) Cdk4 rather than Cdk6, and the immunoprecipitated cyclin D1/Cdk4 holoenzyme was active as a pRB kinase. Electroporation of wild-type pl6CDKN2 arrested the Granta 519 cells in G1, consistent with the p16CDKN2 loss as a biologically relevant event during multistep evolution of the tumor, and with the expression of functional pRB. Direct cooperation of these distinct abnormalities to cell-cycle, deregulation in NHL cells was suggested by G1 acceleration upon inducible overexpression of cyclin D1 in a control breast cancer cell line lacking p16CDKN2, an effect which could be prevented by ectopic expression of p16CDKN2. Taken together, these data suggest that concurrent overexpression of cyclin D1 and functional elimination of p16CDKN2 and p15CDKN2B may characterize certain cases of mantle cell NHL, and that cooperation of the abnormalities is likely to provide a growth advantage of the tumour cells through more efficient inactivation of the RB tumor suppressor. Further clinicopathologic studies of this possibility are warranted.
39 schema:genre research_article
40 schema:inLanguage en
41 schema:isAccessibleForFree true
42 schema:isPartOf N908ab979bdbe4774a5111c2abe2d2896
43 Ndc2d3f86c3954bb394125a7bd4c5bd6d
44 sg:journal.1097065
45 schema:name Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin’s lymphomas. Functional studies in a cell line (Granta 519)
46 schema:pagination 2400555
47 schema:productId N436d70d5635f4e6690b588fd28ab7757
48 N7f3db8f7892d4c0aad52bf21397dd730
49 Nb00a006f2183411eb720ee5f85e3b0e6
50 Nd2c8dbf415b54052b14b8ee6584843fc
51 Nfdce281906c2493fb0fc8fc35ca9347f
52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039379852
53 https://doi.org/10.1038/sj.leu.2400555
54 schema:sdDatePublished 2019-04-11T11:55
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher Nc1a0b917bd474f508bd61aac1f3b6b13
57 schema:url http://www.nature.com/articles/2400555
58 sgo:license sg:explorer/license/
59 sgo:sdDataset articles
60 rdf:type schema:ScholarlyArticle
61 N01f63cb866054265b45cba9ef6a0a9d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Carrier Proteins
63 rdf:type schema:DefinedTerm
64 N056d70be795e4f8ab644ea1fa5e2e955 rdf:first sg:person.01021077160.42
65 rdf:rest Nf745a8512f424d2c8010b5cedd144081
66 N1dac9874c88b481e98981a75adec78bd rdf:first sg:person.01235271253.45
67 rdf:rest Nac77bfe47b6e4f35a9fd937c0adec306
68 N1fe16166d84b484c8d99c585d7dd9538 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Lymphoma, B-Cell
70 rdf:type schema:DefinedTerm
71 N20531dbecab9468c82022ac6f355e697 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Immunophenotyping
73 rdf:type schema:DefinedTerm
74 N209268da5ec64784812e01f975ffe547 rdf:first sg:person.01225221362.51
75 rdf:rest rdf:nil
76 N2151b8c03a7e418d9b6731eaf63972c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Cell Cycle Proteins
78 rdf:type schema:DefinedTerm
79 N29556449e9c14f51abb357cef33600b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Chromosomes, Human, Pair 11
81 rdf:type schema:DefinedTerm
82 N2979b1a1c08b41e8964ac66cedfeb179 rdf:first sg:person.0742723433.90
83 rdf:rest N31fb0a26d8724754b2f4a9fcb25fb009
84 N31fb0a26d8724754b2f4a9fcb25fb009 rdf:first sg:person.01270720062.78
85 rdf:rest N87a72478d83a4b59b54d11d1be19bce8
86 N40b3c8117947485191a1ecb655aba7b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Humans
88 rdf:type schema:DefinedTerm
89 N42d22ca811e845d098a9874b7208c1b5 rdf:first sg:person.016661524712.35
90 rdf:rest Nc5059e70620946a380bda035aba04b19
91 N436d70d5635f4e6690b588fd28ab7757 schema:name pubmed_id
92 schema:value 9001420
93 rdf:type schema:PropertyValue
94 N4a576fee10c5430cb9d2515758886150 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Tumor Cells, Cultured
96 rdf:type schema:DefinedTerm
97 N6a106a6408634b14ae96e1f777b99ddc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Oncogene Proteins
99 rdf:type schema:DefinedTerm
100 N701a29fe40c7448e9c0d6a7c0b8047e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Neoplasm Proteins
102 rdf:type schema:DefinedTerm
103 N7b5a7b5f929d42c792eb303c46bdc43a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Cyclin-Dependent Kinase Inhibitor p16
105 rdf:type schema:DefinedTerm
106 N7f3db8f7892d4c0aad52bf21397dd730 schema:name nlm_unique_id
107 schema:value 8704895
108 rdf:type schema:PropertyValue
109 N809e84cefb994517b8a0da7b1fa46054 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Cyclins
111 rdf:type schema:DefinedTerm
112 N87a72478d83a4b59b54d11d1be19bce8 rdf:first sg:person.01134032473.64
113 rdf:rest N056d70be795e4f8ab644ea1fa5e2e955
114 N908ab979bdbe4774a5111c2abe2d2896 schema:issueNumber 1
115 rdf:type schema:PublicationIssue
116 N9cbcfca7f44c46a6a1a36ffe18719844 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Genes, Tumor Suppressor
118 rdf:type schema:DefinedTerm
119 Nab1c0ae177bc4dc5959d3b28ee4c05b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Gene Deletion
121 rdf:type schema:DefinedTerm
122 Nac77bfe47b6e4f35a9fd937c0adec306 rdf:first sg:person.014452760564.20
123 rdf:rest N2979b1a1c08b41e8964ac66cedfeb179
124 Nad944655514f4c2ba3943781f58a8e5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Translocation, Genetic
126 rdf:type schema:DefinedTerm
127 Nae6f06e8e38d42b1b9240eb681342938 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Aged, 80 and over
129 rdf:type schema:DefinedTerm
130 Nb00a006f2183411eb720ee5f85e3b0e6 schema:name dimensions_id
131 schema:value pub.1039379852
132 rdf:type schema:PropertyValue
133 Nb5e20822d3734ba2b8e56a1da62ed810 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Karyotyping
135 rdf:type schema:DefinedTerm
136 Nb5ebba50be844f7bb1836588d1cc3614 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name RNA, Messenger
138 rdf:type schema:DefinedTerm
139 Nc1a0b917bd474f508bd61aac1f3b6b13 schema:name Springer Nature - SN SciGraph project
140 rdf:type schema:Organization
141 Nc4e63db731b741ba9e6e26cdd869a181 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Cyclin D1
143 rdf:type schema:DefinedTerm
144 Nc5059e70620946a380bda035aba04b19 rdf:first sg:person.01303002216.30
145 rdf:rest N209268da5ec64784812e01f975ffe547
146 Nc8bacf2a19fa4002944b803e2512fc7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Chromosomes, Human, Pair 14
148 rdf:type schema:DefinedTerm
149 Nd2c8dbf415b54052b14b8ee6584843fc schema:name readcube_id
150 schema:value bb960dcc56879c20698181892a3b6e9c60cf1d8c2ee66e759e7e675905f276e1
151 rdf:type schema:PropertyValue
152 Ndc2d3f86c3954bb394125a7bd4c5bd6d schema:volumeNumber 11
153 rdf:type schema:PublicationVolume
154 Ne54245ee36684707b71abaa1ca747db4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Tumor Suppressor Proteins
156 rdf:type schema:DefinedTerm
157 Neb8111e684784106a278f80fdc71dd2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Cyclin-Dependent Kinase Inhibitor p15
159 rdf:type schema:DefinedTerm
160 Neec20345a37446338eee8e36088c3014 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Aged
162 rdf:type schema:DefinedTerm
163 Nefd32212e05e49dfad81b8c75cf1f932 rdf:first sg:person.01013047576.49
164 rdf:rest N1dac9874c88b481e98981a75adec78bd
165 Nf745a8512f424d2c8010b5cedd144081 rdf:first sg:person.016567135244.53
166 rdf:rest N42d22ca811e845d098a9874b7208c1b5
167 Nfdce281906c2493fb0fc8fc35ca9347f schema:name doi
168 schema:value 10.1038/sj.leu.2400555
169 rdf:type schema:PropertyValue
170 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
171 schema:name Medical and Health Sciences
172 rdf:type schema:DefinedTerm
173 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
174 schema:name Oncology and Carcinogenesis
175 rdf:type schema:DefinedTerm
176 sg:journal.1097065 schema:issn 0887-6924
177 1476-5551
178 schema:name Leukemia
179 rdf:type schema:Periodical
180 sg:person.01013047576.49 schema:affiliation https://www.grid.ac/institutes/grid.18886.3f
181 schema:familyName Jadayel
182 schema:givenName D M
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013047576.49
184 rdf:type schema:Person
185 sg:person.01021077160.42 schema:familyName Lens
186 schema:givenName D
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021077160.42
188 rdf:type schema:Person
189 sg:person.01134032473.64 schema:familyName De Schouwer
190 schema:givenName P J
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134032473.64
192 rdf:type schema:Person
193 sg:person.01225221362.51 schema:familyName Catovsky
194 schema:givenName D
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225221362.51
196 rdf:type schema:Person
197 sg:person.01235271253.45 schema:familyName Lukas
198 schema:givenName J
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235271253.45
200 rdf:type schema:Person
201 sg:person.01270720062.78 schema:familyName Stranks
202 schema:givenName G
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270720062.78
204 rdf:type schema:Person
205 sg:person.01303002216.30 schema:familyName Kruger
206 schema:givenName A R
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303002216.30
208 rdf:type schema:Person
209 sg:person.014452760564.20 schema:familyName Nacheva
210 schema:givenName E
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014452760564.20
212 rdf:type schema:Person
213 sg:person.016567135244.53 schema:familyName Bartek
214 schema:givenName J
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016567135244.53
216 rdf:type schema:Person
217 sg:person.016661524712.35 schema:familyName Dyer
218 schema:givenName M J
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016661524712.35
220 rdf:type schema:Person
221 sg:person.0742723433.90 schema:familyName Bartkova
222 schema:givenName J
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742723433.90
224 rdf:type schema:Person
225 sg:pub.10.1038/370183a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009320671
226 https://doi.org/10.1038/370183a0
227 rdf:type schema:CreativeWork
228 sg:pub.10.1038/375503a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034728495
229 https://doi.org/10.1038/375503a0
230 rdf:type schema:CreativeWork
231 sg:pub.10.1038/nm0795-686 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016345098
232 https://doi.org/10.1038/nm0795-686
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1002/gcc.2870050210 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004299310
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/0092-8674(94)90540-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001605098
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/0092-8674(95)90385-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044189874
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1126/science.7809631 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062649804
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1128/mcb.14.3.2066 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014240465
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1128/mcb.14.3.2077 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013411441
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1128/mcb.15.5.2600 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035576061
247 rdf:type schema:CreativeWork
248 https://www.grid.ac/institutes/grid.18886.3f schema:alternateName Institute of Cancer Research
249 schema:name Academic Department of Haematology and Cytogenetics, Institute of Cancer Research, Royal Marsden Hospital Sutton, Surrey, UK.
250 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...